Early Stage Venture Aegle Therapeutics Raises Series A of $6500000

September 28, 2020

About Aegle Therapeutics

Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.

Website: Learn more on Aegle Therapeutics’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Aegle Therapeutics

Amount Raised6500000 USD
Announced Date2020-09-29
Equity Only FundingYes
Organization LocationMiami, Florida, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds3
Lead Investors
Number of Investors5
Number of Partner Investors1